Terashvili M et al. |
Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18492947
|
Snider NT et al. |
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18698000
|
Morin C et al. |
CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi. |
2008 |
Am. J. Respir. Cell Mol. Biol. |
pmid:18757304
|
Smith HE et al. |
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. |
2008 |
Pharmacogenet. Genomics |
pmid:18769365
|
Motoki A et al. |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18835921
|
Behm DJ et al. |
Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:18836067
|
Pfister SL et al. |
Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. |
1991 |
Am. J. Physiol. |
pmid:1887929
|
Force T et al. |
Noncyclooxygenase metabolites of arachidonic acid amplify the vasopressin-induced Ca2+ signal in glomerular mesangial cells by releasing Ca2+ from intracellular stores. |
1991 |
J. Biol. Chem. |
pmid:1900289
|
Falck JR et al. |
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition. |
2009 |
J. Med. Chem. |
pmid:19653681
|
Chen Y et al. |
20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:19762546
|
Merkel MJ et al. |
Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20008276
|
Morin C et al. |
17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:20008283
|
Lamb DC et al. |
Streptomyces coelicolor A3(2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner. |
2010 |
Appl. Environ. Microbiol. |
pmid:20097805
|
Planagumà A et al. |
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4. |
2010 |
Mucosal Immunol |
pmid:20130564
|
Townsley MI et al. |
Impact of epoxyeicosatrienoic acids in lung ischemia-reperfusion injury. |
2010 |
Microcirculation |
pmid:20163540
|
Gross GJ et al. |
Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20400686
|
Yang C et al. |
14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery. |
2010 |
Prostaglandins Other Lipid Mediat. |
pmid:20601071
|
Imaizumi S et al. |
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. |
2010 |
Drug Metab Lett |
pmid:20642447
|
Bukhari IA et al. |
14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries. |
2011 |
J. Pharmacol. Exp. Ther. |
pmid:20881018
|
Skepner JE et al. |
Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21040800
|